Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid peroxidation induced by cyclophosphamide.

M J Berrigan1, R F Struck, H L Gurtoo

  • 1Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo 14263.

Cancer Biochemistry Biophysics
|September 1, 1987
PubMed
Summary

Cyclophosphamide (CP) administration in rats depletes hepatic glutathione, increasing lipid peroxidation. This depletion is a key factor in CP-induced liver damage, showing a dose- and time-dependent relationship.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedine.

Cancer chemotherapy and pharmacology·2001
Same author

A novel tumor necrosis factor-alpha inhibitory protein, TIP-B1.

International journal of immunopharmacology·2001
Same author

Anesthesia for radical prostatectomy, cystectomy, nephrectomy, pheochromocytoma, and laparoscopic procedures.

Anesthesiology clinics of North America·2000
Same author

Synthesis and evaluation of several new (2-chloroethyl)nitrosocarbamates as potential anticancer agents.

Journal of medicinal chemistry·2000
Same author

A novel TNF-inducible message with putative growth suppressor function.

Biochimica et biophysica acta·2000
Same author

DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamide.

Cancer chemotherapy and pharmacology·2000

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Cyclophosphamide (CP) is a widely used chemotherapy agent.
  • CP is known to cause various toxicities, including hepatotoxicity.
  • The precise mechanisms underlying CP-induced liver injury require further elucidation.

Purpose of the Study:

  • To investigate the effects of cyclophosphamide on hepatic glutathione levels.
  • To examine the impact of CP on NADPH-mediated lipid peroxidation in rat liver.
  • To determine the relationship between glutathione depletion and enhanced lipid peroxidation following CP administration.

Main Methods:

  • Intraperitoneal administration of a single dose of cyclophosphamide to rats.
  • Measurement of hepatic glutathione levels.
  • Assay of NADPH-mediated lipid peroxidation in liver homogenates (15,000 x g supernatant).
  • Dose- and time-response studies were conducted.

Main Results:

  • Cyclophosphamide administration resulted in significant hepatic glutathione depletion.
  • CP exposure led to enhanced NADPH-mediated lipid peroxidation in liver supernatant.
  • These effects were observed in a dose- and time-dependent manner.
  • Glutathione depletion correlated with increased lipid peroxidation.

Conclusions:

  • Hepatic glutathione depletion is a significant consequence of cyclophosphamide administration.
  • CP-induced enhancement of lipid peroxidation is, at least partly, mediated by glutathione depletion.
  • These findings contribute to understanding the mechanisms of CP-induced hepatotoxicity.

Related Experiment Videos